InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,220.87
(
-0.01%
)
US TECH 100
17,748.00
(
0.14%
)
Dow Jones
39,430.15
(
0.00%
)
Brent Oil
82.20
(
-1.22%
)
Bitcoin
61,481.42
(
-2.28%
)
Post# of 27649
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Phosphene

Send PM Follow Ignore
Followers 8
Posts 2073
Boards Moderated 0
Alias Born 04/23/2018

Phosphene

Re: None

Monday, 08/13/2018 1:12:20 PM

Monday, August 13, 2018 1:12:20 PM

Post# of 27649
The Company intends to continue to incur additional expenditures during the next six months for additional research and development of our HIV, Influenza
and Chikungunya vaccines, which we will try to seek through collaborations with not-for-profit organizations.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MYMX News
More MYMX News
InvestorsHub NewsWire

FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM

FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM

VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!